IndraLab

Statements


UCHL3 deubiquitinates FOXM1. 3 / 3
1 | 2

reach
"Furthermore, knockdown of UCHL3 increased FOXM1 ubiquitination, which enhanced FOXM1 turnover and promoted pancreatic cancer cells ' sensitivity to gemcitabine."

"Our results demonstrate that <span class="match term0">UCHL3</span> deubiquitinated and stabilized <span class="match term1">FOXM1</span>, thereby potentiating proliferation, migration, and invasion of pancreatic cancer cells."

reach
"Deubiquitination of FOXM1 by UCHL3 was also shown to promote pancreatic cancer progression and gemcitabine resistance."